Matches in Wikidata for { <http://www.wikidata.org/entity/Q84561591> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q84561591 description "2012 թվականի հուլիսի 10-ին հրատարակված գիտական հոդված" @default.
- Q84561591 description "article scientifique publié en 2012" @default.
- Q84561591 description "artículu científicu espublizáu en xunetu de 2012" @default.
- Q84561591 description "scientific article published on 10 July 2012" @default.
- Q84561591 description "wetenschappelijk artikel" @default.
- Q84561591 description "наукова стаття, опублікована в липні 2012" @default.
- Q84561591 name "A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer" @default.
- Q84561591 name "A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer" @default.
- Q84561591 type Item @default.
- Q84561591 label "A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer" @default.
- Q84561591 label "A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer" @default.
- Q84561591 prefLabel "A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer" @default.
- Q84561591 prefLabel "A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer" @default.
- Q84561591 P1433 Q84561591-E8ADACBF-E5B5-446F-B9E8-02A786BB6106 @default.
- Q84561591 P1476 Q84561591-CE88E408-C16A-4B9D-8D37-7A15D78C4662 @default.
- Q84561591 P2093 Q84561591-255DBAD5-C6F7-4397-B2A5-C73B39A5BC6D @default.
- Q84561591 P2093 Q84561591-4A5F0051-4CBB-4FB2-9D8D-0AFE2BFC71C9 @default.
- Q84561591 P2093 Q84561591-5626556A-C7F9-4288-BB25-2EAD2BF82D00 @default.
- Q84561591 P2093 Q84561591-691B1DEA-FD22-462C-84B9-3A434CCAB87D @default.
- Q84561591 P2093 Q84561591-7D35CE87-0B63-43B1-89A9-2D0E3D39ADBC @default.
- Q84561591 P2093 Q84561591-808BB0DA-8019-45D8-9A35-3C72DCFC2403 @default.
- Q84561591 P304 Q84561591-7EF57519-3216-4DD1-9B6F-D080D0CD7FF1 @default.
- Q84561591 P31 Q84561591-E9A6E576-D6B7-4143-A205-9BFF13C4A608 @default.
- Q84561591 P356 Q84561591-E8D41D8C-81D5-4353-8532-6D607F90255F @default.
- Q84561591 P433 Q84561591-87EDCB78-8594-43EC-9A62-499C2691F8AA @default.
- Q84561591 P478 Q84561591-6175027C-E01B-4959-A805-21EFD813B400 @default.
- Q84561591 P577 Q84561591-D7BFC92E-5444-4B10-89CC-2D43311787E0 @default.
- Q84561591 P698 Q84561591-EBF4A9D1-4FEC-40B1-933B-C72898C94D0D @default.
- Q84561591 P921 Q84561591-18BF5079-7808-4473-A009-53C648B5655E @default.
- Q84561591 P921 Q84561591-42C18165-A57F-4868-842E-5BB1D4165C8B @default.
- Q84561591 P921 Q84561591-9F7C4708-3F7D-4896-9384-C20E2C285421 @default.
- Q84561591 P356 MDS122 @default.
- Q84561591 P698 22782331 @default.
- Q84561591 P1433 Q326122 @default.
- Q84561591 P1476 "A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer" @default.
- Q84561591 P2093 "B H Nam" @default.
- Q84561591 P2093 "H T Kim" @default.
- Q84561591 P2093 "H Y Kim" @default.
- Q84561591 P2093 "J S Lee" @default.
- Q84561591 P2093 "J Y Han" @default.
- Q84561591 P2093 "S J Yoon" @default.
- Q84561591 P304 "2925-2930" @default.
- Q84561591 P31 Q13442814 @default.
- Q84561591 P356 "10.1093/ANNONC/MDS122" @default.
- Q84561591 P433 "11" @default.
- Q84561591 P478 "23" @default.
- Q84561591 P577 "2012-07-10T00:00:00Z" @default.
- Q84561591 P698 "22782331" @default.
- Q84561591 P921 Q412197 @default.
- Q84561591 P921 Q412415 @default.
- Q84561591 P921 Q420207 @default.